Patents by Inventor Matthew Patrick Wictome

Matthew Patrick Wictome has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090186368
    Abstract: In an assay, an analyte in a sample is contacted with a thermostable reporter adenylate kinase coupled to a binding agent specific for the analyte, wherein a complex is formed. ADP is added, and then formation of ATP is monitored. Prior to the addition of ADP, endogenous kinase and uncomplexed thermostable reporter adenylate kinase is substantially removed by washing and residual endogenous kinase is inactivated by heating. Prior to contacting the analyte with the thermostable reporter adenylate kinase, the sample has a background activity of at least 300,000 Relative Light Units per mg protein per ml sample when measured in the presence of luciferin/luciferase by a luminometer.
    Type: Application
    Filed: October 14, 2008
    Publication date: July 23, 2009
    Inventors: Neil David Hammond Raven, Matthew Patrick Wictome, J. Mark Sutton, Susan O'Brien, Heather Murdoch
  • Patent number: 6913896
    Abstract: In as assay, an analyte is specifically associated with a reporter adenylate kinase, ADP is added and then formation of ATP is monitored. Prior to addition of ADP, adenylate kinase other than reporter adenylate kinase is removed. Assay apparatus comprises a solid phase on which is immobilised the analyte or an antibody specific for the analyte, a reporter composition comprising a thermostable adenylate kinase coupled to an antibody specific for the analyte, and ADP plus associated reagents for conversion of ADP into ATP by thermostable adenylate kinase.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: July 5, 2005
    Assignee: Health Protection Agency
    Inventors: Neil David Hammond Raven, Matthew Patrick Wictome